Single‐cell RNA sequencing elucidated the landscape of breast cancer brain metastases and identified ILF2 as a potential therapeutic target

• DOI: 10.1111/cpr.13697
• Publication Date: 2024-06-29T09:19:20Z
• Authors: Jindong Xie; Anli Yang; Qianwen Liu; Xinpei Deng; Guangzhao Lv; Xueqi Ou; Shaoquan Zheng; Min‐Yi Situ; Yang Yu; Jie‐Ying Liang; Yutian Zou; Hailin Tang; Zijin Zhao; Fuhua Lin; Wei Liu; Weikai Xiao
• Keywords: 0301 basic medicine; 03 medical and health sciences; Original Article

AbstractDistant metastasis remains the primary cause of morbidity in patients with breast cancer. Hence, the development of more efficacious strategies and the exploration of potential targets for patients with metastatic breast cancer are urgently needed. The data of six patients with breast cancer brain metastases (BCBrM) from two centres were collected, and a comprehensive landscape of the entire tumour ecosystem was generated through the utilisation of single‐cell RNA sequencing. We utilised the Monocle2 and CellChat algorithms to investigate the interrelationships among each subcluster. In addition, multiple signatures were collected to evaluate key components of the subclusters through multi‐omics methodologies. Finally, we elucidated common expression programs of malignant cells, and experiments were conducted in vitro and in vivo to determine the functions of interleukin enhancer‐binding factor 2 (ILF2), which is a key gene in the metastasis module, in BCBrM progression. We found that subclusters in each major cell type exhibited diverse characteristics. Besides, our study indicated that ILF2 was specifically associated with BCBrM, and experimental validations further demonstrated that ILF2 deficiency hindered BCBrM progression. Our study offers novel perspectives on the heterogeneity of BCBrM and suggests that ILF2 could serve as a promising biomarker or therapeutic target for BCBrM.